Oct 29, 2025 02:20AM
Aug 14, 2025 01:20AM
Jun 20, 2025 01:20AM
May 22, 2025 01:20AM
Feb 11, 2025 01:20AM
Dec 27, 2024 01:20AM
Nov 11, 2024 01:20AM Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Nov 4, 2024 01:20AM
Oct 21, 2024 01:20AM
Oct 4, 2024 01:20AM
Sep 23, 2024 01:20AM
Aug 5, 2024 01:20AM
Mar 22, 2024 02:20AM
Mar 22, 2024 02:00AM Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
May 1, 2023 01:10AM
Apr 17, 2023 05:31AM Relief Therapeutics (RLFTF) Reports Positive 12-Month Stability Data for Inhaled and Intravenous RLF-100
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 17, 2023 01:20AM
Apr 14, 2023 01:30AM
Mar 22, 2023 02:30AM
Mar 15, 2023 02:30AM Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA
Feb 28, 2023 01:30AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All